KA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 mai 2024 @ 18:13):

Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners...

Stats
Dagens volum	41 475.00
Gjennomsnittsvolum	399 445
Markedsverdi	5.98M
EPS	$-0.895 ( 2024-05-16 )
Neste inntjeningsdato	( $-0.210 ) 2024-06-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.380
ATR14	$0.00700 (1.44%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Bartoszek Raymond J.	Buy	903 995	Common Stock
2024-04-14	Iadonato Shawn	Buy	225 000	Stock Option (Right to Buy)
2024-04-14	Philips Craig W.	Buy	225 000	Stock Option (Right to Buy)
2024-04-14	Baker Keith	Buy	225 000	Stock Option (Right to Buy)
2024-04-14	Guillaudeux Thierry	Buy	225 000	Stock Option (Right to Buy)

INSIDER POWER
95.46
Last 64 transactions
Buy: 2 929 101 \| Sell: 94 301

Volum Korrelasjon

Lang: -0.14 (neutral)

Kort: 0.32 (neutral)

Signal:(56.423) Neutral

Kineta, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Kineta, Inc. Korrelasjon - Valuta/Råvare

-0.45
( neutral )

-0.35
( neutral )

0.00
( neutral )

0.32
( neutral )

Kineta, Inc. Økonomi

Annual	2023
Omsetning:	$5.44M
Bruttogevinst:	$5.43M (99.83 %)
EPS:	$-1.280

FY	2023
Omsetning:	$5.44M
Bruttogevinst:	$5.43M (99.83 %)
EPS:	$-1.280

FY	2022
Omsetning:	$1.95M
Bruttogevinst:	$1.22M (62.42 %)
EPS:	$-12.80

FY	2021
Omsetning:	$9.09M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.152

Financial Reports:

No articles found.

Kineta, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Kineta, Inc.

Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.